Delivery Order SPE2D020D0014-SPE2D325F3403

Award Date 12/17/24
Potential Completion Date 12/20/24
Potential Value $8.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2D020D0014
    Indefinite Delivery Contract
  • SPE2D020D0014-SPE2D325F3403
    Delivery Order

This federal contract award to Pfizer Inc., valued at $8,460.00, is for the delivery of 4,566,739 vials of 4 mg/10 ml naloxone, an opioid overdose reversal medication. The contract was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, without any set-aside designations.

Pfizer, a large pharmaceutical manufacturer, is the prime contractor on this delivery order. The contract has an ultimate completion date of December 20, 2024. Pfizer also holds several Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $7.31 billion Federal Supply Schedule contract with the Department of Veterans Affairs to provide a range of pharmaceutical products, and a $121.9 million contract with the Centers for Disease Control and Prevention for adult vaccines. These IDVs demonstrate Pfizer's critical role in supplying essential medical products and services to support government healthcare initiatives, from combat readiness to public health programs.

Generated 3/18/25, 9:52 AM